Reneo Pharmaceuticals Quote - RPHM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

18.20

Bid

1.75

Offer

1.88

Volume

0.00 Day's Range 0.00

12.501 52 Week Range 19.30

Market Cap

608.404M

Previous Close

18.20

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

33,428,808

Dividend Yield

PE Ratio

-7.86

Earnings Per Share (EPS)

-2.32

Revenue

Net Profit

-77.39M

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

reneopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was US$18.20. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of US$ 12.501 to US$ 19.30.

Reneo Pharmaceuticals currently has 33,428,808 shares in issue. The market capitalisation of Reneo Pharmaceuticals is US$608.40 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.86.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	18.2	18.2	18.2	0	0	CS
4	0	0	18.2	18.2	18.2	0	0	CS
12	0	0	18.2	18.2	18.2	0	0	CS
26	3.1	20.5298013245	15.1	19	12.501	60827	15.21250478	CS
52	1.9	11.6564417178	16.3	19.3	12.501	127218	15.96323703	CS
156	-32.3	-63.9603960396	50.5	112.95	9.801	186531	29.33833055	CS
260	-134.8	-88.1045751634	153	168.3	9.801	160057	35.91555678	CS

RPHM - Frequently Asked Questions (FAQ)

What is the current Reneo Pharmaceuticals share price?

The current share price of Reneo Pharmaceuticals is US$ 18.20

How many Reneo Pharmaceuticals shares are in issue?

Reneo Pharmaceuticals has 33,428,808 shares in issue

What is the market cap of Reneo Pharmaceuticals?

The market capitalisation of Reneo Pharmaceuticals is USD 608.4M

What is the 1 year trading range for Reneo Pharmaceuticals share price?

Reneo Pharmaceuticals has traded in the range of US$ 12.501 to US$ 19.30 during the past year

What is the PE ratio of Reneo Pharmaceuticals?

The price to earnings ratio of Reneo Pharmaceuticals is -7.86

What is the reporting currency for Reneo Pharmaceuticals?

Reneo Pharmaceuticals reports financial results in USD

What is the latest annual profit for Reneo Pharmaceuticals?

The latest annual profit of Reneo Pharmaceuticals is USD -77.39M

What is the registered address of Reneo Pharmaceuticals?

The registered address for Reneo Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Reneo Pharmaceuticals website address?

The website address for Reneo Pharmaceuticals is reneopharma.com

Which industry sector does Reneo Pharmaceuticals operate in?

Reneo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLGOMicroAlgo Inc	US$ 6.3767 (454.50%)	531.54M
BOXLBoxlight Corporation	US$ 3.1099 (51.70%)	1.84M
GDEVGDEV Inc	US$ 20.90 (46.56%)	264.44k
IVVDInvivyd Inc	US$ 1.7501 (44.64%)	37.75M
UPCUniverse Pharmaceuticals Inc	US$ 0.2003 (40.56%)	420.21M
DOYUDouYu International Holdings Ltd	US$ 7.19 (-55.31%)	1.28M
MNDRMobile health Network Solutions	US$ 0.5048 (-46.29%)	18.61M
BLUEbluebird bio Inc	US$ 4.09 (-41.90%)	5.44M
FLDFold Holdings Inc	US$ 6.95 (-37.39%)	488.54k
GCLGCL Global Holdings Ltd	US$ 3.83 (-31.48%)	635.26k
MLGOMicroAlgo Inc	US$ 6.3767 (454.50%)	531.54M
UPCUniverse Pharmaceuticals Inc	US$ 0.2003 (40.56%)	420.21M
ADTXAditxt Inc	US$ 0.0922 (-22.39%)	278.25M
NVDANVIDIA Corporation	US$ 134.43 (-4.05%)	228.14M
HOLOMicroCloud Hologram Inc	US$ 1.565 (31.51%)	190.81M